News
Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate
25 Mar 24
Earnings, News
Recap: Artelo Biosciences Q4 Earnings
25 Mar 24
Earnings
Artelo Biosciences FY23 EPS $(3.14) Vs $(3.56) YoY
25 Mar 24
Earnings, News
Artelo Biosciences Has Been Granted European Patent Number EP3723752 Titled "NEW SOLID FORMS OF CANNABIDIOL AND USES THEREOF (FOR VARIOUS MEDICAL TREATMENTS)"
20 Mar 24
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
6 Mar 24
Movers
Artelo Biosciences Announces Publication Of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness In Treating And Preventing Oxaliplatin-Induced Peripheral Neuropathy
23 Jan 24
Biotech, News, General
Artelo Biosciences Announces Selection Of Worldwide Clinical Trials As Clinical Research Organization To Support First-In-Human Study Of ART26.12
8 Jan 24
Biotech, News, General
Press releases
Artelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challenge
12 Mar 24
Health Care, Press Releases
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
23 Jan 24
Press Releases